Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Cancer Research|February 1, 1984
Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight lossR T Chlebowski, D Heber, B Richardson, et al.
Journal of the American Dietetic Association|April 1, 1995
Dietary intake and counseling, weight maintenance, and the course of HIV infectionR T Chlebowski, M Grosvenor, L Lillington, et al.
Cancer Treatment Reports|January 1, 1982
Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell lineR T Chlebowski, J B Block, D Cundiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Current attitudes and practice of American Society of Clinical Oncology-member clinical oncologists regarding cancer prevention and controlR T Chlebowski, J Sayre, M Frank-Stromborg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifeneR T Chlebowski, D E Collyar, M R Somerfield, et al.
Cancer|October 15, 1981
Treatment of advanced breast carcinoma with 5-fluorouracil: a randomized comparison of two routes of deliveryR T Chlebowski, R P Pugh, J M Weiner, et al.
Cancer Practice|November 1, 1993
Factors influencing nurses' breast cancer control activityL B Lillington, G V Padilla, J W Sayre, et al.
Cancer|December 1, 1978
Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trialR T Chlebowski, R Hestorff, L Sardoff, et al.
Cancer Treatment Reports|April 1, 1984
Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibitionJ B Block, R T Chlebowski, M F Dietrich, et al.
Controlled Clinical Trials|June 1, 1981
Factors influencing the interim interpretation of a breast cancer trial: danger of achieving the "expected" resultR T Chlebowski, J M Weiner, V M Ryden, et al.
Pageof 8